1. Spexin Acts as Novel Regulator for Bile Acid Synthesis
   Cheng-yuan Lin et al, 2018, Front. Physiol. CrossRef
2. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway
   Min Song et al, 2019, J. Agric. Food Chem. CrossRef
3. Modulatory Nano/Micro Effects of Diabetes Development on Pharmacology of Primary and Secondary Bile Acids Concentrations
   Armin Mooranian et al, 2020, CDR CrossRef
4. Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat
   Hanlin Zhang et al, 2021, Exp Ther Med CrossRef
5. Pharmacological Dose-Effect Profiles of Various Concentrations of Humanised Primary Bile Acid in Encapsulated Cells
   Armin Mooranian et al, 2022, Nanomaterials CrossRef
6. Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice
   Yan Hao et al, 2022, Front. Microbiol. CrossRef
7. The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
   Youchao Qi et al, 2022, Molecules CrossRef
8. Bile acids and microbes in metabolic disease
   Dhiraj Kumar Sah et al, 2022, World J Gastroenterol CrossRef
9. Oral Administration of Taurodeoxycholate, A GPCR19 Agonist, Effectively Ameliorates Atopic Dermatitis in A Mouse Model
   Aziz Ghaderpour et al, 2024, Experimental Dermatology CrossRef
10. Chenodeoxycholic acid alleviated the cyclosporine-induced nephrotoxicity by decreasing oxidative stress and suppressing renin-angiotensin system through AT2R and ACE2 mRNA upregulation in rats
    İlknur Bingül et al, 2025, J Mol Histol CrossRef